tirzepatide nafld glp 1 liver disease glp-1 fatty Multiple target tissue effects of analogues on non-alcoholic (NAFLD) and non-alcoholic steatohepatitis (NASH) The Emerging Role of Glucagon-Like – Effects of GLP-1 receptor agonists – Recent guidelines for Non-Alcoholic Fatty

The author holds equity interest in RNA Therapeutics Inc, DEI Biopharma Inc, Abyolo, and BioRx Inc, but none of these create any conflict of interest for this paper

In conditions characterized by chronic immune dysregulation, such as autoimmunity in Long COVID, the failure of this delicate S-glutathionylation process contributes to sustained tissue damage and cellular miscommunication

Our findings suggest semaglutide might have neuroprotective effects beyond managing blood sugar levels

Whether any of that holds is a question about evidence, and the evidence is genuinely contradictory rather than merely thin

10:30 - Shawn gets into the biochemistry of caffeine - 1,3,7-trimethylxanthine When you metabolize it -- de-methylate it -- you end up with three other di -methylxanthines